セリアック病治療の世界市場

セリアック病治療の世界市場は2030年までに11億米ドルに達する見込み

2024年に5億9,710万米ドルと推定されるセリアック病治療の世界市場は、分析期間2024-2030年にCAGR 11.2%で成長し、2030年には11億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるビタミン・ミネラル治療は、CAGR 12.9％を記録し、分析期間終了時には5億8,680万米ドルに達すると予測されます。グルテンフリー食治療分野の成長率は、分析期間中CAGR 10.3％と推定されます。

米国市場は1億6,270万米ドルと推定、中国はCAGR15.5％で成長予測

米国のセリアック病治療市場は、2024年に1億6,270万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR15.5%で推移し、2030年には2億3,750万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.9%と10.0%と予測されています。欧州では、ドイツがCAGR約8.9%で成長すると予測されています。

世界のセリアック病治療市場- 主要動向と促進要因のまとめ

なぜセリアック病治療の需要が増加しているのか？

セリアック病治療の需要が増加している背景には、グルテン関連疾患に対する意識の高まり、診断技術の向上、世界のセリアック病の有病率の増加があります。セリアック病はグルテンの摂取によって引き起こされる自己免疫疾患で、腸管障害、吸収不良、様々な健康合併症を引き起こします。セリアック病と診断される人が増えるにつれ、厳格なグルテン除去食以外の効果的な治療法に対する需要が高まっています。

高度な診断検査が可能になったことで、セリアック病がより早く、より正確に特定されるようになり、治療を必要とする患者層が拡大しています。さらに、グルテン過敏症や未診断のセリアック病に伴う長期的な健康リスクに対する消費者の意識が高まり、医療介入の需要が高まっています。酵素を用いた治療、免疫療法、腸内細菌叢の調整など、新しい治療法の研究が勢いを増しており、生涯にわたる食事制限に代わる治療法を求める患者に新たな希望をもたらしています。

技術の進歩はどのようにセリアック病治療を改善しているのか？

バイオテクノロジー、精密医療、治療薬開発における技術革新は、グルテン回避にとどまらない新たな解決策を提供することで、セリアック病治療に変化をもたらしています。最も重要な進歩の一つは、グルテンが免疫反応を引き起こす前に消化管内でグルテンを分解するように設計された経口酵素療法の開発です。これらの酵素を使った治療は、患者が偶発的にグルテンに暴露されても、症状や腸管障害を軽減できるように設計されています。

また、グルテンに対する体の反応を変化させる免疫調整薬の研究も進んでいます。研究開発者は、グルテンを許容するように免疫系を再教育したり、腸管障害を引き起こす炎症反応をブロックすることを目的とした治療法を開発しています。さらに、腸内細菌叢（マイクロバイオーム）研究の進歩により、腸内環境をより健康にし、セリアック関連の炎症を抑えるプロバイオティクスを用いた治療に新たな可能性が生まれています。また、遺伝子スクリーニングツールの統合により、早期診断と個別化治療アプローチが改善され、より効果的な疾患管理が可能となっています。

セリアック病治療業界の成長を牽引する市場動向は？

グルテンフリーの医薬品や栄養補助食品に対する消費者の需要の増加は、セリアック病治療市場を形成する最も影響力のある動向の一つです。食品や医薬品に含まれる二次汚染や隠れグルテンの影響に対する認識が高まるにつれ、グルテンフリーの医療用認証製品の開発が重視されるようになっています。この動向は、医薬品、ビタミン剤、その他の治療がセリアック病患者にとって安全であることを保証するよう製薬会社を駆り立てています。

市場成長に影響を与えるもう一つの主要動向は、疾患修飾薬の臨床試験の拡大です。複数の製薬企業が、セリアック病患者に長期的な救済を提供することを目的としたワクチン、生物製剤、酵素ベースの治療薬の臨床試験を積極的に実施しています。さらに、食事管理や症状追跡のためのデジタルヘルスプラットフォームやモバイルアプリの統合は、患者が病状をより効果的に管理するのに役立っています。規制状況の進展に伴い、新規のセリアック病治療薬の承認が加速し、食事療法にとどまらないより包括的な治療オプションが提供されることが期待されます。

セリアック病治療市場の将来を形作る主な成長促進要因は何か？

セリアック病治療市場の成長は、研究資金の増加、診断率の上昇、治療イノベーションの進展など、いくつかの要因によってもたらされます。主な成長要因の一つは、グルテンフリーの食事療法にとどまらない標的治療薬の開発における製薬会社やバイオテクノロジー企業の役割の拡大です。臨床試験や創薬への積極的な投資により、セリアック病治療のパイプラインは着実に成長しています。

市場を形成するもう一つの重要な促進要因は、認知度の向上と早期発見を目的とした政府やヘルスケアによる取り組みの活発化です。多くの国では、未診断のセリアック病の負担を軽減するため、スクリーニング・プログラムや患者教育キャンペーンを実施しています。また、食品企業と製薬企業の協力により、より効果的なグルテン検出ツールやより安全な食事療法の開発が進んでいます。科学が新たな治療経路を発見し続ける中、セリアック病管理の将来は、個別化医療、食事支援、医薬品介入の組み合わせが含まれるようになり、世界中の患者の生活の質が向上すると思われます。

セグメント

治療（ビタミン・ミネラル治療、グルテンフリー食治療、医療療法治療）、投与経路（経口投与経路、非経口投与経路）、流通チャネル（病院流通チャネル、研究センター流通チャネル、その他流通チャネル）

調査対象企業の例

• 9 Meters Biopharma, Inc.
• Anokion SA
• Barinthus Biotherapeutics
• Chugai Pharmaceutical Co., Ltd.
• Cour Pharmaceuticals
• Equillium, Inc.
• Falk Pharma GmbH
• Immunic, Inc.
• ImmunogenX
• Mozart Therapeutics
• Nemysis Ltd
• Novartis AG
• Pfizer Inc.
• Precigen ActoBio
• Protagonist Therapeutics, Inc.
• Provention Bio, Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
• Theriva Biologics
• Zedira GmbH

AIインテグレーション

当社は、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Celiac Disease Treatment Market to Reach US$1.1 Billion by 2030

The global market for Celiac Disease Treatment estimated at US$597.1 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.2% over the analysis period 2024-2030. Vitamins & Minerals Treatment, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$586.8 Million by the end of the analysis period. Growth in the Gluten-Free Diet Treatment segment is estimated at 10.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$162.7 Million While China is Forecast to Grow at 15.5% CAGR

The Celiac Disease Treatment market in the U.S. is estimated at US$162.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$237.5 Million by the year 2030 trailing a CAGR of 15.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.9% and 10.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.

Global Celiac Disease Treatment Market - Key Trends & Drivers Summarized

Why Is the Demand for Celiac Disease Treatment Increasing?

The demand for celiac disease treatment is increasing due to rising awareness of gluten-related disorders, improved diagnostic techniques, and a growing prevalence of celiac disease worldwide. Celiac disease is an autoimmune condition triggered by gluten consumption, leading to intestinal damage, malabsorption, and a range of health complications. As more individuals are diagnosed with the condition, there is an increasing demand for effective treatment options beyond a strict gluten-free diet.

The availability of advanced diagnostic tests has led to earlier and more accurate identification of celiac disease, expanding the patient pool requiring treatment. Additionally, growing consumer awareness about gluten sensitivity and the long-term health risks associated with undiagnosed celiac disease has increased the demand for medical intervention. Research into novel therapies, including enzyme-based treatments, immunotherapies, and gut microbiome modulation, is gaining momentum, providing new hope for patients seeking alternatives to lifelong dietary restrictions.

How Are Technological Advancements Improving Celiac Disease Treatment?

Innovations in biotechnology, precision medicine, and therapeutic drug development are transforming celiac disease treatment by offering new solutions beyond gluten avoidance. One of the most significant advancements is the development of oral enzyme therapies designed to break down gluten in the digestive tract before it triggers an immune response. These enzyme-based treatments are being designed to help patients manage accidental gluten exposure, reducing symptoms and intestinal damage.

Another breakthrough is the exploration of immune-modulating drugs that can alter the body’s reaction to gluten. Researchers are developing therapies that aim to retrain the immune system to tolerate gluten or block the inflammatory response that causes intestinal damage. Additionally, advancements in gut microbiome research have opened new possibilities for probiotic-based treatments that promote a healthier intestinal environment and reduce celiac-related inflammation. The integration of genetic screening tools is also improving early diagnosis and personalized treatment approaches, ensuring more effective management of the disease.

Which Market Trends Are Driving Growth in the Celiac Disease Treatment Industry?

The increasing consumer demand for gluten-free pharmaceuticals and dietary supplements is one of the most influential trends shaping the celiac disease treatment market. As awareness grows about the impact of cross-contamination and hidden gluten in food and medications, there is a greater emphasis on developing certified gluten-free medical products. This trend is driving pharmaceutical companies to ensure that medications, vitamins, and other treatments are safe for individuals with celiac disease.

Another key trend influencing market growth is the expansion of clinical trials for disease-modifying drugs. Several pharmaceutical companies are actively conducting trials for vaccines, biologics, and enzyme-based therapies that aim to provide long-term relief for celiac disease patients. Additionally, the integration of digital health platforms and mobile apps for diet management and symptom tracking is helping patients manage their condition more effectively. As the regulatory landscape evolves, the approval of novel celiac disease treatments is expected to accelerate, providing more comprehensive care options beyond dietary modifications.

What Are the Key Growth Drivers Shaping the Future of the Celiac Disease Treatment Market?

The growth in the celiac disease treatment market is driven by several factors, including increased research funding, rising diagnosis rates, and advancements in therapeutic innovation. One of the primary growth drivers is the expanding role of pharmaceutical and biotech companies in developing targeted therapies that go beyond gluten-free diets. With strong investments in clinical trials and drug discovery, the pipeline for celiac disease treatments is steadily growing.

Another crucial driver shaping the market is the increasing government and healthcare initiatives to improve awareness and early detection. Many countries are implementing screening programs and patient education campaigns to reduce the burden of undiagnosed celiac disease. Additionally, collaborations between food companies and pharmaceutical firms are leading to the development of more effective gluten detection tools and safer dietary solutions. As science continues to uncover new treatment pathways, the future of celiac disease management will likely include a combination of personalized medicine, dietary support, and pharmaceutical intervention, ensuring better quality of life for patients worldwide.

SCOPE OF STUDY:

The report analyzes the Celiac Disease Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Vitamins and Minerals Treatment, Gluten-Free Diet Treatment, Medical Therapies Treatment); Route of Administration (Oral Route of Administration, Parenteral Route of Administration); Distribution Channel (Hospitals Distribution Channels, Research Centers Distribution Channels, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• 9 Meters Biopharma, Inc.
• Anokion SA
• Barinthus Biotherapeutics
• Chugai Pharmaceutical Co., Ltd.
• Cour Pharmaceuticals
• Equillium, Inc.
• Falk Pharma GmbH
• Immunic, Inc.
• ImmunogenX
• Mozart Therapeutics
• Nemysis Ltd
• Novartis AG
• Pfizer Inc.
• Precigen ActoBio
• Protagonist Therapeutics, Inc.
• Provention Bio, Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
• Theriva Biologics
• Zedira GmbH

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Celiac Disease Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Celiac Disease Throws the Spotlight on Therapeutic and Dietary Management Solutions
  • Growing Awareness and Early Diagnosis Rates Propel Demand for Celiac Disease Treatment and Intervention Options
  • Unmet Need Beyond Gluten-Free Diets Expands the Addressable Market for Pharmacological Therapies
  • Innovation in Enzyme Therapy and Immune Modulation Strengthens the Business Case for Drug Development Pipelines
  • Increased Focus on Gut Barrier Protection Drives Interest in Novel Celiac Disease Therapeutic Mechanisms
  • Pipeline Advancements in Peptide-Based and Biologic Therapies Accelerate Industry Investment in Targeted Treatments
  • Rising Incidence of Non-Responsive Celiac Disease Spurs Clinical Demand for Advanced Treatment Alternatives
  • Growing Consumer Adoption of Gluten-Free Diets Drives Demand for Nutraceuticals and Functional Support Products
  • Regulatory Fast-Track Designations and Orphan Drug Incentives Support Accelerated Approval Pathways
  • Digital Tools and Symptom-Tracking Apps Enhance Patient Engagement and Treatment Adherence
  • Healthcare Provider Education and Specialist Referral Programs Improve Access to Celiac Disease Management
  • Expansion of Diagnostic Testing Infrastructure Fuels Earlier Intervention and Therapeutic Need
  • Global Gluten-Free Food Market Growth Supports Adjunctive Dietary Management Approaches
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Celiac Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Celiac Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Vitamins & Minerals Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Vitamins & Minerals Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Vitamins & Minerals Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Gluten-Free Diet Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Gluten-Free Diet Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Gluten-Free Diet Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Medical Therapies Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Medical Therapies Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Medical Therapies Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Oral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Oral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Parenteral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Parenteral Route of Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Parenteral Route of Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Research Centers Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Research Centers Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Research Centers Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• JAPAN
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• CHINA
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• EUROPE
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Celiac Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• FRANCE
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• GERMANY
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Celiac Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• INDIA
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Celiac Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Celiac Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Celiac Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030
• AFRICA
  • Celiac Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Celiac Disease Treatment by Treatment - Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Celiac Disease Treatment by Treatment - Percentage Breakdown of Value Sales for Vitamins & Minerals Treatment, Gluten-Free Diet Treatment and Medical Therapies Treatment for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Celiac Disease Treatment by Route Of Administration - Oral Route of Administration and Parenteral Route of Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Celiac Disease Treatment by Route Of Administration - Percentage Breakdown of Value Sales for Oral Route of Administration and Parenteral Route of Administration for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Celiac Disease Treatment by Distribution Channel - Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Celiac Disease Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospitals Distribution Channels, Research Centers Distribution Channels and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION